In COVID-19 clinical update #69, Daniel Griffin covers effectiveness of mRNA vaccines against the delta variant, depression among public health workers, correlates of protection against asymptomatic and symptomatic infection, BNT162b2 in ChAdOx-1-S primed individuals, prior infection rescues B and T cell responses to variants after vaccination, effect of vaccination on household transmission, germinal responses induced by mRNA vaccines, phase 3 results of Novavax vaccine, and long COVID as our next national health disaster.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Worry about human behavior, not variants (NY Times)
- Moderna and Pfizer vaccines vs delta variant
- Depression among public health workers (MMWR)
- Correlates of protection (medRxiv)
- mRNA vaccine in AZ recipients (Lancet)
- Prior infection rescues B and T cell responses to variants (Science)
- Effect of vaccination on household transmission (NEJM)
- mRNA vaccines induce germinal responses (Nature)
- Novavax vaccine phase 3 results (NEJM)
- EUA for tocilizumab (FDA)
- Long COVID, next national health disaster (NEJM)
- Letters read on TWiV 775
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]
